FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

CDER Quality Office Seeks Site Visit Participants

[ Price : $8.95]

Federal Register Notice: FDA announces a 2017 CDER Office of Pharmaceutical Quality Staff Experiential Learning Site Visit Program...

FDA Clears Xtant Medical Irix-C Cervical Cage

[ Price : $8.95]

FDA clears a Xtant Medical Holdings 510(k) for the Irix-C cervical cage for use with autograft or allograft and the expansion of t...

Greenleaf Health Brings on 2 Former FDA Officials

[ Price : $8.95]

Regulatory consulting firm Greenleaf Health hires two former senior FDA officials former Office of Regional Operations director D...

FDA, Others Warned on Finalizing Regs Before Trump in Office

[ Price : $8.95]

House Republican leaders write FDA commissioner Robert Califf and other federal agency heads to caution them against finalizing pe...

Draft FDA Software Guidance Raises Questions

[ Price : $8.95]

Two Morgan, Lewis attorneys outline questions and concerns raised by a recent FDA draft guidance on clinical evaluation of softwar...

Progress Seen in Pediatric Studies

[ Price : $8.95]

Experts surveyed to update a Tufts Center for the Study of Drug Development report on pediatric drug studies see efforts moving in...

CGMP Violations Found in Japans Sekisui Medical

[ Price : $8.95]

FDA warns Japans Sekisui Medical Co. about CGMP and data integrity issues in its manufacturing of active pharmaceutical ingredient...

FTC Enforcement Policy on OTC Homeopathic Drug Claims

[ Price : $8.95]

The Federal Trade Commission announces a new Enforcement Policy Statement on Marketing Claims for Over-the-Counter (OTC) Homeopath...

Patient Advocates Help Develop Rare Disease Products

[ Price : $8.95]

Contract research organization executives at Premier Research discuss ways in which patient advocates play a lead role with FDA an...

Device Recalls Up, Drugs Down: Stericycle

[ Price : $8.95]

Stericycles third quarter recall index shows an increase in medical device recalls and a decrease in pharmaceutical recalls.